Published in

American Chemical Society, Journal of Medicinal Chemistry, 19(65), p. 12701-12724, 2022

DOI: 10.1021/acs.jmedchem.2c00496

Links

Tools

Export citation

Search in Google Scholar

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety

Journal article published in 2022 by Stefano Sainas ORCID, Marta Giorgis ORCID, Paola Circosta ORCID, Giulio Poli, Marta Alberti ORCID, Alice Passoni ORCID, Valentina Gaidano ORCID, Agnese C. Pippione ORCID, Nicoletta Vitale, Davide Bonanni ORCID, Barbara Rolando ORCID, Alessandro Cignetti ORCID, Cristina Ramondetti ORCID, Alessia Lanno ORCID, Davide M. Ferraris and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Orange circle
Postprint: archiving restricted
  • Must obtain written permission from Editor
  • Must not violate ACS ethical Guidelines
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO